115 related articles for article (PubMed ID: 8455331)
1. [Clinical evaluation of cefpodoxime in respiratory tract infections].
Fukuhara H; Irabu Y; Kakazu T; Nakamura H; Shigeno Y; Saito A; Owan T; Oshiro H; Miyaguni T; Nakasone K
Jpn J Antibiot; 1993 Jan; 46(1):53-9. PubMed ID: 8455331
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of cefpodoxime proxetil, a new oral cephem, in the treatment of respiratory tract infections with the special reference to community-acquired Streptococcus Pneumoniae infections].
Akiyama O; Ito T; Ogata M; Okano H; Kabe J; Kawakami M; Kida K; Kudo K; Komatsuzaki K; Konno K
Jpn J Antibiot; 1995 Apr; 48(4):522-8. PubMed ID: 7783315
[TBL] [Abstract][Full Text] [Related]
3. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
Kimura H; Takeuchi H; Ishikawa H; Hayakawa F; Yamamoto N; Nakao Y; Kuno K
Jpn J Antibiot; 1989 Jul; 42(7):1593-606. PubMed ID: 2562789
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic and clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Fujimoto T; Yokochi K; Yamashita F
Jpn J Antibiot; 1989 Jul; 42(7):1629-66. PubMed ID: 2681864
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies of cefpodoxime proxetil in respiratory tract infections].
Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Takahashi H; Numata H; Takahashi K; Yamaki I; Ishii S
Jpn J Antibiot; 1988 Oct; 41(10):1538-44. PubMed ID: 3204658
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of a new oral cephem, cefpodoxime proxetil in children].
Meguro H; Arimasu O; Shiraishi H; Tajima T; Hiruma F; Nishimura S; Sugie N; Sugamata K; Abe T; Fujii R
Jpn J Antibiot; 1989 Jul; 42(7):1561-70. PubMed ID: 2810730
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of clinical efficacy and safety of cefpodoxime proxetil (CPDX-PR) in acute uncomplicated cystitis].
Furusawa T; Hiratake Y; Mishina T; Ooe H; Maegawa M; Furudama H; Hida S; Itoh M; Inoue S; Nakagawa K
Hinyokika Kiyo; 1994 Sep; 40(9):853-60. PubMed ID: 7801852
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
Takeuchi H; Ikoma H; Suzuki T; Nakajima M; Kouzaki Y; Ishizu Y; Makino H; Sugihara S; Ootawara S; Asagi K
Jpn J Antibiot; 1994 Jan; 47(1):84-92. PubMed ID: 8114275
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
[TBL] [Abstract][Full Text] [Related]
10. [Laboratory and clinical studies of cefpodoxime proxetil in pediatric field].
Nishimura T; Tabuki K; Aoki S; Takagi M
Jpn J Antibiot; 1989 Jul; 42(7):1607-20. PubMed ID: 2810732
[TBL] [Abstract][Full Text] [Related]
11. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
Safran C
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].
Akita H; Sato Y; Iwata S; Sunakawa K
Jpn J Antibiot; 1989 Jul; 42(7):1547-60. PubMed ID: 2810729
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic, bacteriological and clinical evaluation of cefpodoxime proxetil in pediatrics].
Iwai N; Taneda Y; Nakamura H; Miyazu M; Kasai K
Jpn J Antibiot; 1989 Jul; 42(7):1571-92. PubMed ID: 2810731
[TBL] [Abstract][Full Text] [Related]
14. Once-a-day therapy of cefpodoxime proxetil for respiratory tract infections.
Sawae Y; Ninomiya K; Sumida I; Inoue T; Takaki K; Okada K; Kumagai Y; Ishimaru T; Shimono N; Misumi H
J Chemother; 1995 Nov; 7 Suppl 4():134-6. PubMed ID: 8904134
[No Abstract] [Full Text] [Related]
15. [Clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
Haruta T; Kuroki S; Hashimoto N; Suzuki N; Okura K; Kobayashi Y
Jpn J Antibiot; 1989 Jul; 42(7):1621-8. PubMed ID: 2562790
[TBL] [Abstract][Full Text] [Related]
16. [A clinical evaluation of cefpodoxime proxetil in pediatrics].
Minamitani M; Hachimori K; Kaneda K
Jpn J Antibiot; 1989 Jul; 42(7):1488-97. PubMed ID: 2810725
[TBL] [Abstract][Full Text] [Related]
17. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
Balfour JA; Benfield P
Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies of cefpodoxime proxetil in pediatric field].
Kimura S; Yokoyama M; Kudo M; Aoyama R; Okamoto T; Tsushima N; Onodera N; Ikeda Y
Jpn J Antibiot; 1989 Jul; 42(7):1477-87. PubMed ID: 2810724
[TBL] [Abstract][Full Text] [Related]
19. Cefpodoxime proxetil in upper respiratory tract infections.
Bergogne-Berezin E
Drugs; 1991; 42 Suppl 3():25-33. PubMed ID: 1726205
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of cefpodoxime proxetil in the pediatric field].
Niino K; Sato H; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Nakazawa S
Jpn J Antibiot; 1989 Jul; 42(7):1505-18. PubMed ID: 2810727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
